Monsanto Cancer Roundup Suits Not Derailed by EPA Finding

Personal injury suits against Monsanto over its herbicide Roundup may take a blow, but not a fatal one, from a recent EPA finding in the company's favor.

The agency preliminarily found that the active ingredient glyphosate is unlikely to be a human carcinogen. The Environmental Protection Agency, in its Glyphosate Issue Paper: Evaluation of Carcinogenic Potential, said “the strongest support is for” a determination that glyphosate is “‘not likely to be carcinogenic to humans’ at doses relevant to human health risk assessment.”

“Exposures vary widely, from children in residences where the herbicide was used to agricultural workers with heavy exposure. Additional fact questions may be present because of these variations.” Roundup has been in wide use in home and commercial settings throughout the United States since the product was first released by Monsanto for sale in 1974. Believing it was safe, many Americans have inadvertently exposed themselves to the Roundup cancer risk at no fault of their own. To get more information about the round up cancer and harmful effects, you can hop over to monsantoroundupcancerlawsuit.com

Attorneys for the plaintiffs are undeterred by the EPA finding. Approximately 150 plaintiffs have filed suits against Monsanto over its Roundup product, including three dozen federal suits consolidated Oct. 3 in the U.S. District Court for the Northern District of California and state court filings in Delaware and Missouri.

The plaintiffs allege Roundup can cause non-Hodgkin’s lymphoma, and that Monsanto failed to warn consumers and regulators about the alleged risks.